1. Home
  2. ENTX vs FNWB Comparison

ENTX vs FNWB Comparison

Compare ENTX & FNWB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Entera Bio Ltd.

ENTX

Entera Bio Ltd.

HOLD

Current Price

$1.62

Market Cap

142.0M

Sector

Health Care

ML Signal

HOLD

Logo First Northwest Bancorp

FNWB

First Northwest Bancorp

HOLD

Current Price

$9.42

Market Cap

83.1M

Sector

Finance

ML Signal

HOLD

Company Overview

Basic Information
Metric
ENTX
FNWB
Founded
2010
1923
Country
Israel
United States
Employees
N/A
N/A
Industry
Biotechnology: Biological Products (No Diagnostic Substances)
Banks
Sector
Health Care
Finance
Exchange
Nasdaq
Nasdaq
Market Cap
142.0M
83.1M
IPO Year
2018
2015

Fundamental Metrics

Financial Performance
Metric
ENTX
FNWB
Price
$1.62
$9.42
Analyst Decision
Strong Buy
Buy
Analyst Count
1
1
Target Price
$10.00
$13.50
AVG Volume (30 Days)
208.2K
40.8K
Earning Date
11-14-2025
01-28-2026
Dividend Yield
N/A
1.51%
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$124,000.00
$54,052,000.00
Revenue This Year
N/A
$31.86
Revenue Next Year
N/A
$10.64
P/E Ratio
N/A
N/A
Revenue Growth
25.25
6.47
52 Week Low
$1.50
$6.05
52 Week High
$3.22
$12.10

Technical Indicators

Market Signals
Indicator
ENTX
FNWB
Relative Strength Index (RSI) 33.35 44.58
Support Level $1.53 $9.26
Resistance Level $1.99 $9.48
Average True Range (ATR) 0.19 0.15
MACD -0.01 -0.08
Stochastic Oscillator 12.07 27.03

Price Performance

Historical Comparison
ENTX
FNWB

About ENTX Entera Bio Ltd.

Entera Bio Ltd is a clinical-stage biopharmaceutical company engaged in the development of orally delivered macromolecule therapeutics, including peptides and therapeutic proteins. The company focuses on underserved, chronic medical conditions where oral administration of a mini tablet peptide or peptide replacement therapy has the potential to significantly shift a treatment paradigm. Its product candidates are; EB613 for the treatment of osteoporosis and EB612 for the treatment of hypoparathyroidism are first-in-class mini tablet formulations of synthetic human PTH (1-34) (teriparatide), designed to have differing pharmacokinetic, or PK, profiles.

About FNWB First Northwest Bancorp

First Northwest Bancorp is a bank holding company and a financial holding company and is engaged in banking activities through its wholly owned subsidiary, First Fed Bank, as well as certain non-banking financial activities. It includes deposit and lending transactions that are supplemented with other borrowing and investing activities. The bank's principal lending activities are focused on first lien one- to four-family mortgage loans, commercial and multi-family real estate loans, construction and land loans, commercial business loans, and consumer loans.

Share on Social Networks: